Infantile hemangioma;Hémangiome infantile

Presse Medicale

Volumn 39, Issue 4, 2010, Pages 499-510

  Léauté Labrèze, Christine ^a   Sans Martin, Véronique ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; BETAMETHASONE; CORTICOSTEROID; FIBROBLAST GROWTH FACTOR 2; PREDNISOLONE; PREDNISONE; PROPRANOLOL; TRANSFORMING GROWTH FACTOR BETA; TRIAMCINOLONE; VASCULOTROPIN; VINCRISTINE;

CARBON DIOXIDE LASER; CONGENITAL MALFORMATION; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; ERBIUM YAG LASER; HEMANGIOMA; HUMAN; INFANTILE HEMANGIOMA; PATHOPHYSIOLOGY; SHORT SURVEY; TUMOR REGRESSION;

EID: 77951090377     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2009.10.015     Document Type: Short Survey

References (57)

1. Enjolras O., Mulliken J.B. Vascular tumors and vascular malformations, new issues. Adv Dermatol 1997, 13:375-423.
2. Khan Z.A., Boscolo E., Picard A., Psutka S., Melero-Martin J., Bartch T., et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 2008, 118:2592-2599.
3. Frieden I.J., Haggstrom A., Drolet B.A., Mancini A.J., Friedlander S.F., Boon L., et al. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas. Pediatr Dermatol 2005, 22:383-406.
4. Boye E., Yu Y., Paranya G., Mulliken J.B., Olsen B.R., Bischoff J. Clonality and altered behaviour of endothelial cells from hemangiomas. J Clin Invest 2001, 107:745-752.
5. North P.E., Waner M., Mizeracki A., Mrak R.E., Nicholas R., Kincannon J., et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001, 137:559-570.
6. Yu Y., Flint A.F., Mulliken J.B., Wu J.K., Bischoff J. Endothelial progenitor cells in infantile hemangiomas. Blood 2004, 103:1373-1375.
7. Bielenberg D.R., Bucana C.D., Sanchez R., Mulliken J.B., Folkman J., Fidler I.J. Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor INF-beta. Int J Oncol 1999, 14:401-408.
8. Walter J.W., North P.E., Waner M., Mizeracki A., Blei F., Walker J.W., et al. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangiomas. Genes Chromosomes Cancer 2002, 33:295-303.
9. Kleinman M.E., Greives M.R., Churgin S.S., Blechman K.M., Chang E.I., Ceradini D.J., et al. Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma. Arterioscler Thromb Vasc Biol 2007, 27:2664-2670.
10. Chang E.I., Thangarajah H., Hamou C., Gurtner G.C. Hypoxia, hormones, and endothelial progenitor cells in hemangioma. Lymphat Res Biol 2007, 5:237-243.
11. Lopez Gutierrez J.C., Avila L.F., Sosa G., Patron M. Placental anomalies in children with infantile hemangiomas. Pediatr Dermatol 2007, 24:353-355.
12. Mancini A.J., Smoller B.R. Proliferation and apoptosis within juvenile capillary hemangiomas. Am J Dermatopathol 1996, 18:505-514.
13. Razon M.J., Kraling B.M., Mulliken J.B., Bischoff J. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation 1998, 5:189-195.
14. Nakayama H. Clinical and histological studies of the classification and the natural course of the strawberry mark. J Dermatol 1981, 8:277-291.
15. Haggstrom A.N., Lammer E.J., Schneider R.A., Marcucio R., Frieden I.J. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006, 117:698-703.
16. Haggstrom A.N., Drolet B.A., Baselga E., Chamlin S.L., Garzon M.C., Horii K.A., et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006, 118:882-887.
17. Waner M., North P.A., Scherer K.A., Frieden I.J., Waner A., Mihm M.C. The non-random distribution of facial hemangiomas. Arch Dermatol 2003, 139:869-875.
18. Chiller K.G., Passaro D., Fieden I.J. Hemangiomas of infancy clinical characteristics, morphologic subtypes and their relationship to race, ethnicity and sex. Arch Dermatol 2002, 138:1567-1576.
19. Metry D.W., Hawrot A., Altman C., Frieden I.J. Association of solitary, segmental hemangiomas of the skin with visceral hemangiomatosis. Arch Dermatol 2004, 140:591-596.
20. Rahbar R., Nicollas R., Roger G., Triglia J.M., Garabedian E.N., McGill T.J., et al. The biology and management of sub-glottic hemangioma: past, present, future. Laryngoscope 2004, 114:1880-1891.
21. Kassarjian A., Zurakowski D., Dubois J., Paltiel H.J., Fishman S.J., Burrows P.E., et al. Infantile hepatic hemngiomas: clinical and imaging findings and their correlation with therapy. AJR 2004, 182:785-795.
22. Christison-Lagay E.R., Burrows P.E., Alomari A., Dubois J., Kozakewich H.P., Lane T.S., et al. Hepatic hemangioma, subtype classification, and development of a clinical practice algorithm and registry. J Pediatr Surg 2007, 42:62-67.
23. Bruckner A.L., Frieden I.J. Hemangiomas of infancy. J Am Acad Dermatol 2003, 48:477-493.
24. Margileth A.M., Museles M. Cutaneous hemangiomasin children: diagnosis and conservative management. J Am Med Assoc 1965, 194:523-526.
25. Frieden I.J., Reese V., Cohen D. PHACE syndrome: the association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 1996, 132:307-311.
26. Metry D.W., Haggstrom A.N., Barkovich A.J., Frieden I.J. The many faces of PHACE syndrome. J Pediatr 2001, 139:117-123.
27. Mazereeuw-Hautier J., Syed S., Harper J.I. Sternal malformation/vascular dysplasia syndrome with linear hypopigmentation. Br J Dermatol 2006, 155:192-194.
28. Metry D.W., Haggstrom A.N., Drolet B.A., Baselga E., Chamlin S., Garzon M., et al. A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings and complications. Am J Med Genet A 2006, 140:975-986.
29. Drolet B.A., Dohil M., Golomb M.R., Wells R., Murowski L., Tamburro J., et al. Early stroke and cerebral vasculopathy in children with facial hemangiomas and PHACE association. Pediatrics 2006, 117:959-964.
30. Girard C., Bigorre M., Guillot B., Bessis D. PELVIS syndrome. Arch Dermatol 2006, 142:884-888.
31. Stockman A., Boralevi F., Taïeb A., Leauté-Labrèze C. SACRAL syndrome: spinal dysraphism, anogenital, cutaneous, renal and urologic anomalies, associated with an angioma of lumbosacral localization. Dermatology 2007, 214:40-45.
32. Hoeve L.J., Küppers G.L.E., Verwoerd C.D.A. Management of infantile subglottic hemangioma: laser vaporization, submucous resection, intubation or intralesional steroids? Oto Rhino Laryngol 1997, 42:179-186.
33. Yap E.Y., Bartley G.B., Hohberger G.G. Periocular capillary hemangioma: a review for pediatricians and family physicians. Mayo Clin Proc 1998, 73:753-759.
34. Dubois J., Milot J., Jaeger B.I., McCuaig C., Rousseau E., Powell J. Orbit and eyelid hemangiomas: is there a relationship between location and ocular problems? J Am Acad Dermatol 2006, 55:614-619.
35. Millischer-Bellaiche A.E., Enjolras O., Andre C., Bursztyn J., Kalifa G., Adamsbaum C. Les hémangiomes palpébraux du nourisson. J Radiol 2004, 85:2019-2028.
36. Metz B.J., Rubenstein M.C., Levy M.L., Metry D.W. Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor. Arch Dermatol 2004, 140:867-870.
37. Tanner J.L., Dechert M.P.B.A., Frieden I.J. Growing up with a facial hemangioma: parent and child coping and adaptation. Pediatrics 1998, 101:446-452.
38. Frieden I.J., Eichenfield L.F., Esterly N.B., Geronemus R., Mallory S.B. Guidelines of care for hemangiomas of infancy. Am Acad Dermatol Guidelines/Outcomes Committee JAAD 1997, 37:631-637.
39. Hasan Q., Tan S.T., Gush J., Peters S.G., Davis P.F. Steroid therapy of a proliferating hemangioma: histochemichal and molecular changes. Pediatrics 2000, 105:117-120.
40. Bennet M.L., Fleischer A.B., Chamlin S.L., Frieden I.J. Oral corticosteroid use is effective for cutaneous hemangiomas An evidence-based evaluation. Arch Dermatol 2001, 137:1208-1213.
41. Enjolras O., Riche M.C., Merland J.J., Escande J.P. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 1990, 85:491-498.
42. George M.E., Sharma V., Jacobson J., Simon S., Nopper A.J. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol 2004, 140:963-969.
43. Ezekowitz R.A.B., Phil C.B.D., Mulliken J.B., Folkman J. Interferon alpha-2a therapy for life-threatening hemangiomas of infancy. New Engl J Med 1992, 326:1456-1463.
44. Michaud A.P., Bauman N.M., Burke D.K., Manaligod J.M., Smith R.J. Spastic diplegia and other motor disturbances in infants receiving interferon alpha. Laryngoscope 2004, 114:1231-1236.
45. Enjolras O., Breviere G.M., Roger G., Tovi M., Pellegrino B., Varotti E., et al. Traitement par vincristine des hémangiomes graves du nourrisson. Arch Pediatr 2004, 11:99-107.
46. Shorr N., Seiff S.R. Central retinal artery occlusion associated with periocular corticosteroid injection for juvenile hemangioma. Ophtalmic Surg 1986, 17:229-231.
47. Picard A., Soupre V., Diner P.A., Buis J., Goga D., Vazquez M.P. Chirurgie précoce des hémangiomes immatures à l'aide d'un dissecteur ultrasons. Étude à propos de 81 cas. Rev Stomatol Chir Maxillofac 2002, 103:10-21.
48. Faguer K., Dompmartin A., Labbé D., Barrelier M.T., Leroy D., Théron J. Early surgical treatment of Cyrano nose hemangiomas with Rethi incision. Br J Plast Surg 2002, 55:498-503.
49. David L.R., Malek M.M., Argenta L.C. Efficacity of pulsed dye laser therapy for the treatment of ulcerated hemangiomas: a review of 78 patients. Br J Plast Surg 2003, 56:317-327.
50. Ho N.T., Lansang P., Pope E. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study. J Am Acad Dermatol 2007, 56:63-68.
51. Villain E., Denjoy I., Lupoglasoff J.M., Guicheney P., Haingue B., Lucet V., Bonnet D. Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome. Eur Heart J 2004, 25:1405-1411.
52. Fritz K.I., Bhat A.M. Effect of beta-blockade on symptomatic dexamathasone-induced hypertrophic obstructive cardiomyopathy in premature infants: three case reports and literature review. J Perinatol 1998, 18:38-44.
53. Kilian K. Hypertension in neonates causes and treatment. J Perinat Neonatal Nurs 2003, 17. 75-74.
54. Leauté-Labrèze C., Dumas de la Roque E., Hubiche T., Boralevi F., Thambo J.B., Taieb A. Propranolol for severe hemangiomas of infancy. New Engl J Med 2008, 358(24):2650-2651.
55. Theletsane T., Redfern A., Raynham O., Harris T., Prose N.S., Khumalo N.P. Life-threatening infantile haemangioma: a dramatic response to propranolol. J Eur Acad Dermatol Venereol 2009, 23.
56. Denoyelle F., Leboulanger N., Enjolras O., Harris R., Roger G., Garabedian E.N. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol 2009, 73(8):1168-1172.
57. Sans V., Dumas de la Roque E., Berge J., Grenier N., Boralevi F., Mazereeuw-Hautier J., Lipsker D., et al. Propranolol for severe infantile hemangiomas: Follow-Up Report. Pediatrics 2009, 124:e423-e431.